Sathi Roy’s OHM debuts at SCOPE Miami, showcasing India’s spiritual-tech visionSathi Roy, founder of Our Highest Mantra, presented a new human development platform at the SCOPE Art Show. The platform combines ancient I...
GetVantage invests in logistics firms Celcius Logistics, Ohm Logistics and FitsolGetVantage, an embedded finance fintech platform, has invested in three logistics companies - Celcius Logistics, Ohm Logistics, and Fitsol....
Ashok Leyland to fully acquire OHM India, to infuse Rs 300 crThe acquisition is a part of the company's EV strategy to engage in the business of eMaaS (e-Mobility as a Service). This would likely resu...
Ashok Leyland in discussions to raise funds for e-mobility service arm Ohm along with EV subsidiary SwitchWhile the company was non-committal on the quantum of fund raise for Ohm, ET learns the company may be looking at raising anywhere between ...
Ashok Leyland to transfer EV business to step-down armAlso, the board at its meeting held on Friday has approved the transfer of its eMaaS (e-mobility as a service) business for Rs 65 crore to ...
DSP small cap fund sells 3% in Eveready IndustriesAll three funds bought the stakes at Rs 200 per share.
Quirky’s Ohm bluetooth speaker charges wirelessly, so it’s always readyOn the surface, the Rs 10,500 (approx) Ohm is a pretty standard Bluetooth speaker block that allows you to play music wirelessly.
Ranbaxy Laboratories recalls 29,790 packs of anti-allergy drug in USRanbaxy Laboratories is recalling 29,790 blister packs of anti-allergy drug in the US, manufactured by its arm Ohms Laboratories, due to de...
Ranbaxy to suffer operating losses post USFDA ban: Surajit Pal, Prabhudas Lilladher"For the Ohm Labs to manufacture formulations, around 70% of the supplies came from the Toansa API plant. So that business would be impacte...
Ranbaxy's US unit gets USFDA's establishment inspection reportThe US health regulator has given Ranbaxy Laboratories' American arm Ohm Laboratories Inc a report indicating closure of inspection of its ...
Ranbaxy rallies 19%: Just another flash in the pan, say analystsHowever, analysts are not expecting the stock to continue with its uptrend as USFDA overhang remains.
Ranbaxy may shift key drug filings from Mohali to USConsidering its US facility is already running chock-a-bloc, analysts feel, the company may cherry-pick and transfer its first to file ANDA...
Ranbaxy shares fall over 5% as trouble brews in US marketThe stock plunged over 5% on reports that the US-based Ohm Laboratories-the company's facility in US, is under the surveillance of FDA.
- Angel recommends 'Sell' on Ranbaxy Laboratories
Angel Broking has recommended a sell rating for Ranbaxy Laboratories after a warning was issued against the company from US FDA for its Ohm...
- Ranbaxy Laboratories is over-priced: Emkay
Emkay Global Financial Services is of the view that the warning to Ranbaxy Laboratories’ Ohm plant will sentimentally dampen its stock pric...
- US FDA issues warning letter to Ranbaxy's American subsidiary
The US Food and Drug Administration issued a warning letter to Ranbaxy Labs' American subsidiary for violating current good manufacturing p...
- Ranbaxy gets nod to market Cetirizine in US
Ranbaxy Laboratories has received final approval from the US Food and Drug Administration to manufacture and market Cetirizine Hydrochlorid...